Results 191 to 200 of about 922,822 (266)

The PSA test for prostate cancer screening: an abridged Cochrane review

open access: yesBJU International, EarlyView.
Objectives To assess the effects of prostate cancer screening compared to no screening in men with no prior diagnosis of prostate cancer. Methods This systematic review represents an update of a prior Cochrane review from 2013, searching multiple databases up to November 2025. We included randomised controlled trials (RCTs) of prostate cancer screening
Juan V. A. Franco   +6 more
wiley   +1 more source

Medico-legal implications of functional septorhinoplasty according to Sulsenti: distinction from aesthetic surgery. [PDF]

open access: yesActa Otorhinolaryngol Ital
Ricciardiello F   +6 more
europepmc   +1 more source

Surgical waiting times in patients with high‐ and low‐risk renal cell carcinoma in England

open access: yesBJU International, EarlyView.
Objectives To assess to what extent hospitals meet the uniform English National Health Service ‘timely’ treatment standard, what happens after a breach, and determinants of delay for patients with high‐risk renal cell carcinoma (RCC). Patient and Methods Population‐based study using linked data for 7030 patients with high‐risk and 10 708 patients with ...
Raghav Varma   +13 more
wiley   +1 more source

Gliomas with pleomorphic and pseudopapillary features (GPAP) are circumscribed tumors with targetable mutations, prolonged survival, and frequent tumor predisposition

open access: yesBrain Pathology, EarlyView.
DNA methylation profiling identifies GPAP as a distinct circumscribed glioma with a characteristic expansive, multicystic radiological appearance, pleomorphic and pseudopapillary histology, a recognizable CNV profile, druggable molecular alterations, and recurrent cancer predisposition syndromes.
Alberto Picca   +35 more
wiley   +1 more source

Interaction with NEGR1 affects mGlu5 cell signalling and the neuroprotection induced by the positive allosteric modulator VU0409551

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Background and Purpose The metabotropic glutamate receptor mGlu5 plays an important role in neuronal survival and synaptic plasticity. We and others have shown that mGlu5 positive allosteric modulators (PAMs) are biased agonists, triggering the activation of neuroprotective pathways and promoting neuronal survival. As mGlu5 biased pharmacology
Jennifer D. S. Guimaraes   +14 more
wiley   +1 more source

A snapshot of Italian nursing homes for people with dementia: A national survey of 1671 facilities. [PDF]

open access: yesJ Alzheimers Dis
Vaccaro R   +10 more
europepmc   +1 more source

Behaviour Support in Dentistry Core Outcomes (BeSiDe‐CO): A Core Outcome Set Development Study

open access: yesCommunity Dentistry and Oral Epidemiology, EarlyView.
ABSTRACT Objectives To develop a Core Outcome Set suitable for adults and children for use in studies of Dental Behaviour Support (DBS) techniques, including non‐pharmacological DBS, sedation and General Anaesthesia research. Methods Two systematic reviews generated a preliminary list of candidate outcomes that were shared with Key Stakeholders (KSG ...
Caoimhin Mac Giolla Phadraig   +22 more
wiley   +1 more source

Five‐Year Treatment Outcomes of Macular Oedema Secondary to Central Retinal Vein Occlusion in Routine Clinical Practice: The Fight Retinal Blindness! Registry

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To report 5‐year outcomes in a cohort of patients who received anti‐VEGF therapy for macular oedema secondary to central retinal vein occlusion (CRVO) in routine clinical practice. Methods In this retrospective observational study, 593 treatment‐naïve eyes that commenced anti‐VEGF treatment between 1 January 2010, and 2019 were ...
Katrin Rudolph   +10 more
wiley   +1 more source

Towards an environmentally sustainable and resilient healthcare system: a roadmap for Italy. [PDF]

open access: yesFront Public Health
Punzo O   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy